David Lee

David Lee, RAC, is a Regulatory Program Director CMC at Genentech since 2025, with extensive experience in regulatory affairs across various biotechnology companies. Previously, David held positions including Associate Director, Regulatory CMC at Poseida Therapeutics, Inc. and Manager, Regulatory Affairs CMC at Aeglea BioTherapeutics. David has also worked at bluebird bio as Manager/Senior Manager, Regulatory Science CMC, and has gained analytical expertise through roles at ImmunoGen, Inc. and Lonza. Currently, David is pursuing a Master’s degree at City University of New York-Hunter College while also completing a Bachelor's degree at Brandeis University.